Themes US R&D Champions ETF
USRD
2 hedge funds and large institutions have $20.3K invested in Themes US R&D Champions ETF in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
21,734% more capital invested
Capital invested by funds: $93 → $20.3K (+$20.2K)
100% more funds holding
Funds holding: 1 → 2 (+1)
1.7% more ownership
Funds ownership: 0.01% → 1.71% (+1.7%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GWM
Geneos Wealth Management
Englewood,
Colorado
|
+$20.3K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$939 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GWM
1
Geneos Wealth Management
Englewood,
Colorado
| $19.3K | +$20.3K | +650 | New |
|
|
2
UBS Group
Zurich,
Switzerland
| $981 | +$939 | +30 | +1,000% |
|
USRD Hedge Fund Activity: Q4 2024 in Review
2 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Themes US R&D Champions ETF (USRD) for Q4 2024, worth a combined $20.3K — up 21,734% from $93 a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new USRD positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Geneos Wealth Management, opening a new position worth an estimated $20.3K.
- 2 institutional investors held Themes US R&D Champions ETF (USRD) as of Q4 2024, up from 1 in Q3 2024.
- Funds reported $20.3K of Themes US R&D Champions ETF stock for Q4 2024, up 21,734% quarter-over-quarter.
- 1 fund opened new Themes US R&D Champions ETF positions in Q4 2024 and 0 closed out, a net change of +1 holder.
- The largest Themes US R&D Champions ETF buyer in Q4 2024 was Geneos Wealth Management, an estimated $20.3K added.
Based on aggregated 13F filings for Q4 2024.